Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
-
* Corresponding author: Frank Westermann f.westermann@dkfz.de
- Equal contributors
Genome Biology 2008, 9:R150 doi:10.1186/gb-2008-9-10-r150
Accesses
- Last 30 days: 92 accesses
- Last year: 983 accesses
- All time: 4659 accesses
Cited by
BioMed Central: 3 citations
|
Abra G Brisbin, Yan W Asmann, Honglin Song, Ya-Yu Tsai, Jeremiah A Aakre, Ping Yang, Robert B Jenkins, Paul Pharoah, Fredrick Schumacher, David V Conti, David J Duggan, Mark Jenkins, John Hopper, Steven Gallinger, Polly Newcomb, Graham Casey, Thomas A Sellers, Brooke L Fridley BMC Medical Genetics 2011, 12:156 (5 December 2011) |
|
Nadine Van Roy, Katleen De Preter, Jasmien Hoebeeck, Tom Van Maerken, Filip Pattyn, Pieter Mestdagh, Joëlle Vermeulen, Jo Vandesompele, Frank Speleman Genome Med 2009, 1:74 (27 July 2009) Genomic, epigenetic and microRNA changes influence the development and severity of neuroblastoma, and copy number variations can now be used to form genomic subgroups which correlate with clinical outcome.
|
|
A novel and universal method for microRNA RT-qPCR data normalization Pieter Mestdagh, Pieter Van Vlierberghe, An De Weer, Daniel Muth, Frank Westermann, Frank Speleman, Jo Vandesompele Genome Biology 2009, 10:R64 (16 June 2009) The mean expression value: a new method for accurate and reliable normalization of microRNA expression data from RT-qPCR experiments. |